BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10487851)

  • 1. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations.
    Chu PG; Chang KL; Chen WG; Chen YY; Shibata D; Hayashi K; Bacchi C; Bacchi M; Weiss LM
    Am J Pathol; 1999 Sep; 155(3):941-7. PubMed ID: 10487851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
    de Campos-Lima PO; Levitsky V; Brooks J; Lee SP; Hu LF; Rickinson AB; Masucci MG
    J Exp Med; 1994 Apr; 179(4):1297-305. PubMed ID: 7511684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
    Fassone L; Cingolani A; Martini M; Migliaretti G; Oreste PL; Capello D; Gloghini A; Vivenza D; Dolcetti R; Carbone A; Antinori A; Gaidano G; Larocca LM
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):19-26. PubMed ID: 11804553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
    Chen YY; Chang KL; Chen WG; Shibata D; Hayashi K; Weiss LM
    Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited sequence heterogeneity of Epstein-Barr virus nuclear antigen 1 in benign and malignant EBV-associated disorders.
    Schuster V; Ott G; Seidenspinner S; Kreth HW
    Infection; 2000; 28(3):137-42. PubMed ID: 10879636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.
    Gottschalk S; Ng CY; Perez M; Smith CA; Sample C; Brenner MK; Heslop HE; Rooney CM
    Blood; 2001 Feb; 97(4):835-43. PubMed ID: 11159505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States.
    Gaal K; Weiss LM; Chen WG; Chen YY; Arber DA
    Lab Invest; 2002 Jul; 82(7):957-62. PubMed ID: 12118098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
    Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
    J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
    Midgley RS; Bell AI; Yao QY; Croom-Carter D; Hislop AD; Whitney BM; Chan AT; Johnson PJ; Rickinson AB
    J Virol; 2003 Nov; 77(21):11507-16. PubMed ID: 14557636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
    Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
    Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin's disease.
    Chang KL; Chen YY; Chen WG; Hayashi K; Bacchi C; Bacchi M; Weiss LM
    Blood; 1999 Jul; 94(1):244-50. PubMed ID: 10381519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
    J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R; Kurilla MG; de Campos-Lima PO; Wallace LE; Dolcetti R; Murray RJ; Rickinson AB; Masucci MG
    J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.